RCM
EW icon

Reynolds Capital Management’s Edwards Lifesciences EW Stock Holding History

Reynolds Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30,000
Closed -$711K – 143
2015
Q3 		$711K Buy
30,000
+6,600
+28% +$159K 0.89% 31
2015
Q2 		$555K Sell
23,400
-5,400
-19% -$122K 0.54% 53
2015
Q1 		$684K Buy
28,800
+1,800
+7% +$40.4K 0.6% 41
2014
Q4 		$573K Sell
27,000
-3,000
-10% -$60.3K 0.48% 62
2014
Q3 		$511K Buy
+30,000
New +$474K 0.5% 57

Other funds holding EW

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Reynolds Capital Management's EW Position: Q4 2015 in Review

Reynolds Capital Management sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 30,000 shares — an estimated $711K sold.

Reynolds Capital Management first reported a position in EW in Q3 2014 and held it in 5 quarters. The position peaked at $711K in Q3 2015. 605 funds tracked by Wall St. Rank hold EW as of Q4 2015.

  • Reynolds Capital Management reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
  • Reynolds Capital Management sold 30,000 Edwards Lifesciences shares in Q4 2015, an estimated $711K.
  • Reynolds Capital Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 5 quarters.
  • Reynolds Capital Management's Edwards Lifesciences position peaked at $711K in Q3 2015.
  • 605 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on Reynolds Capital Management's 13F filing for Q4 2015, filed 11 Jan 2016.